Universal Health Services, Inc. - Ordinary Shares - Class B
UHS
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
78.4% upsideUndervalued by 78.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.15 Billion |
|---|---|
| Enterprise Value | $14.15 Billion |
| Dividend Yield | $0.80 (0.55%) |
| Earnings per Share | $23.42 |
| Beta | 1.13 |
| Outstanding Shares | 61,065,149 |
Return
| Return on Equity | 20.19% |
|---|---|
| Return on Assets | 9.70% |
| Return on Invested Capital | 17.53% |
Valuation & Multiples
| P/E Ratio | 5.87 |
|---|---|
| PEG | 58.06 |
| Price to Sales | 0.49 |
| Price to Book Ratio | 1.16 |
| Enterprise Value to Revenue | 0.8 |
| Enterprise Value to EBIT | 6.49 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.1054▼ 17.12% |
|---|---|
| Total Calls | 117,600▼ 60.27% |
| Total Puts | 130,000▼ 65.60% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 80.67%▲ 1.41% |
|---|---|
| Total Invested | $9.18B▼ 17.43% |
| Investors Holding | 656▼ 46.00% |
ESG Score
No data
About Universal Health Services, Inc.
90,000 employees
CEO: Alan Miller Universal Health Services, Inc. is one of the nation's largest hospital companies, operating, through its subsidiaries, behavioral health facilities, acute care hospitals, and ambulatory centers throughout the United States, Puerto Rico and the United Kingdom.
Relevant Senate Committees
This is a highly relevant committee, controlling taxation (corporate tax policy directly impacts UHS's profitability), trade, and critically, entitlement spending (Medicare/Medicaid), which are fundamental revenue streams and regulatory drivers for hospital companies.
This committee directly allocates discretionary federal spending, which determines the precise cash flow and reimbursement rates for major federal healthcare programs (e.g., Medicare, Medicaid) that are primary revenue sources for UHS.
This committee directly regulates core aspects of the healthcare industry, including drug approval (affecting medical supplies used by UHS) and, critically, labor laws (minimum wage, unions), which are major cost drivers for hospital systems.
This committee's oversight of antitrust laws and the DOJ is highly relevant to UHS, as the hospital industry frequently undergoes mergers and acquisitions that are subject to antitrust scrutiny, directly impacting growth strategies and market consolidation.
This committee drafts the budget resolution that sets overall federal spending ceilings, critically influencing the funding levels for major healthcare programs like Medicare and Medicaid, which are primary revenue sources for UHS.
UHS provides healthcare services, and funding decisions by this committee for the Department of Veterans Affairs directly impact reimbursement and patient volume from veterans, a significant demographic for healthcare providers.